Back to CVE records
High 8.8Published Aug 10, 2026

CVE-2026-18617Data-science-pipelines-operator: dspo: mysql dsn parameter injection via customextraparams enables local infile file exfiltration from operator pod

Updated under an hour ago ()

Does this affect you?

It affects Red Hat OpenShift AI 2.25. Add what you run to find out whether that includes you.

No exploitation reported and no EPSS estimate yet.

A flaw was found in the Data Science Pipelines Operator (DSPO). A namespace editor can exploit a vulnerability in the spec.database.customExtraParams field, which allows for the injection of dangerous parameters into the MySQL Data Source Name (DSN) string. By manipulating these parameters, an attacker can enable LOCAL INFILE functionality and exfiltrate sensitive files, such as the service account token, from the operator pod. This can lead to privilege escalation, allowing a namespace editor to gain cluster-admin privileges.

CVSS
8.8 HIGH (v3.1, CNA)CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
Weakness (CWE)
CWE-915
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
Not loaded for this CVE
Assigned by
redhat
NVD analysis
Awaiting Analysis
Record last updated
Sep 21, 2026
First seen by InfoSec Signals
Oct 9, 2026

Affected products

Affected products
from 1785189332 not affected
CNA record

References

  • vendor-advisory, x-refsource-redhat
  • vendor-advisory, x-refsource-redhat
  • vendor-advisory, x-refsource-redhat
  • vendor-advisory, x-refsource-redhat
  • vendor-advisory, x-refsource-redhat
  • vendor-advisory, x-refsource-redhat
  • vdb-entry, x-refsource-redhat
  • issue-tracking, x-refsource-redhat

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.